Downloadable Webcasts:

Update on hereditary melanoma and genetic testing

Using pathologic and histopathologic information to predict SLN positivity, micrometastatic disease, systemic metastasis, and survival

Update on histologic and molecular markers for melanoma

What's different about the 7th edition of the AJCC staging system?

Methods of biopsy; Mohs micrographic surgery vs standard resection for MIS; and the value of imiquimod

SLNB: Decoding the controversies regarding its use and significance

Interpreting the latest data on various adjuvant IFN regimens for high-risk melanoma

Optimizing imaging studies for baseline assessment and surveillance of melanoma

Molecularly targeted therapies for melanoma and current strategies for overcoming resistance to systemic therapies

Managing adverse effects and improving patient compliance

Publications:

Advances in Melanoma Staging and Surgical Techniques

Interpreting Developments in Melanoma Treatment

Pathogenesis and Predictors of Prognosis in Melanoma

Clinical Perspectives in Melanoma

A report on advances in Melanoma from the 2022 European Society for Medical Oncology (ESMO) meeting in Stockholm, Sweden

Insights in Melanoma

Highlights from the 2022 Perspectives in Melanoma XII meeting in The Hague, The Netherlands

Oncology Nursing Update: Bridging Available Treatments to Best-Case Outcomes in Melanoma

A summary of melanoma presentations from the Oncology Nursing Society s 33rd Annual Congress by Rosemary Giuliano, ARNP, MSN; John M. Kirkwood, MD; and Kathleen Madden, FNP-BC, AOCNP